A Study of mRNA-1647 Cytomegalovirus Vaccine in Liver Transplant Candidates and Recipients
Conditions: Cytomegalovirus Infection Interventions: Biological: mRNA-1647; Biological: Placebo Sponsors: ModernaTX, Inc. Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
More News: Cytomegalovirus | Liver | Liver Transplant | Research | Study | Transplant Surgery | Transplants | Urology & Nephrology | Vaccines